
Top stories



LegalConCourt sets precedent with first GAAR interpretation, Absa loses appeal
Bowmans tax team 3 hours



More news


Construction & Engineering
R750m hotel and conference centre to reshape Waterfall City’s built environment
















Background
The optimum use of cytotoxic drugs for advanced colorectal cancer has not been defined. Our aim was to investigate whether combination treatment is better than sequential administration of the same drugs in patients with advanced colorectal cancer.
Read the rest of the article here. Please note: you must register in order to access articles on The Lancet site.